Fisher & Paykel Healthcare FSPKF Stock
Fisher & Paykel Healthcare Price Chart
Fisher & Paykel Healthcare FSPKF Financial and Trading Overview
| Fisher & Paykel Healthcare stock price | 26.01 USD |
| Previous Close | 26.01 USD |
| Open | 26 USD |
| Bid | 23.54 USD x 40000 |
| Ask | 28.46 USD x 40000 |
| Day's Range | 26 - 26.53 USD |
| 52 Week Range | 19.01 - 26.53 USD |
| Volume | 220 USD |
| Avg. Volume | 449 USD |
| Market Cap | 15.3B USD |
| Beta (5Y Monthly) | 0.876 |
| PE Ratio (TTM) | 55.340427 |
| EPS (TTM) | 0.47 USD |
| Forward Dividend & Yield | 0.3 (1.14%) |
| Ex-Dividend Date | June 22, 2026 |
| 1y Target Est | N/A |
FSPKF Valuation Measures
| Enterprise Value | 14.95B USD |
| Trailing P/E | 55.340427 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | 43.7 |
| Price/Sales (ttm) | 6.628153 |
| Price/Book (mrq) | 12.862202 |
| Enterprise Value/Revenue | 6.477 |
| Enterprise Value/EBITDA | 19.688 |
Trading Information
Fisher & Paykel Healthcare Stock Price History
| Beta (5Y Monthly) | 0.876 |
| 52-Week Change | 24.15% |
| S&P500 52-Week Change | 14.57% |
| 52 Week High | 26.53 USD |
| 52 Week Low | 19.01 USD |
| 50-Day Moving Average | 24.98 USD |
| 200-Day Moving Average | 22.97 USD |
FSPKF Share Statistics
| Avg. Volume (3 month) | 449 USD |
| Avg. Daily Volume (10-Days) | 70 USD |
| Shares Outstanding | 588.25M |
| Float | 584.99M |
| Short Ratio | N/A |
| % Held by Insiders | 3.68% |
| % Held by Institutions | 38.47% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.52 |
| Trailing Annual Dividend Yield | 1.99% |
| 5 Year Average Dividend Yield | 145.00% |
| Payout Ratio | 0.5422 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2026 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | March 31, 2027 |
Profitability
| Profit Margin | 20.29% |
| Operating Margin (ttm) | 28.71% |
| Gross Margin | 63.68% |
| EBITDA Margin | 32.89% |
Management Effectiveness
| Return on Assets (ttm) | 14.71% |
| Return on Equity (ttm) | 23.39% |
Income Statement
| Revenue (ttm) | 2.31B USD |
| Revenue Per Share (ttm) | 3.93 USD |
| Quarterly Revenue Growth (yoy) | 14.00% |
| Gross Profit (ttm) | 1.47B USD |
| EBITDA | 759.4M USD |
| Net Income Avi to Common (ttm) | 468.5M USD |
| Diluted EPS (ttm) | 0.47 |
| Quarterly Earnings Growth (yoy) | 14.09% |
Balance Sheet
| Total Cash (mrq) | 461.1M USD |
| Total Cash Per Share (mrq) | 0.79 USD |
| Total Debt (mrq) | 146.1M USD |
| Total Debt/Equity (mrq) | 6.91 USD |
| Current Ratio (mrq) | 2.315 |
| Book Value Per Share (mrq) | 2.0222044 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 663.2M USD |
| Levered Free Cash Flow (ttm) | 399.41M USD |
Profile of Fisher & Paykel Healthcare
| Country | United States |
| State | N/A |
| City | Auckland |
| Address | 15 Maurice Paykel Place |
| ZIP | 2013 |
| Phone | 64 9 574 0100 |
| Website | https://www.fphcare.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 7357 |
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, the company provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP), and nasal high flow products. Further, it offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
Q&A For Fisher & Paykel Healthcare Stock
What is a current FSPKF stock price?
Fisher & Paykel Healthcare FSPKF stock price today per share is 26.01 USD.
How to purchase Fisher & Paykel Healthcare stock?
You can buy FSPKF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Fisher & Paykel Healthcare?
The stock symbol or ticker of Fisher & Paykel Healthcare is FSPKF.
Which industry does the Fisher & Paykel Healthcare company belong to?
The Fisher & Paykel Healthcare industry is Medical Instruments & Supplies.
How many shares does Fisher & Paykel Healthcare have in circulation?
The max supply of Fisher & Paykel Healthcare shares is 588.27M.
What is Fisher & Paykel Healthcare Price to Earnings Ratio (PE Ratio)?
Fisher & Paykel Healthcare PE Ratio is 55.34042700 now.
What was Fisher & Paykel Healthcare earnings per share over the trailing 12 months (TTM)?
Fisher & Paykel Healthcare EPS is 0.47 USD over the trailing 12 months.
Which sector does the Fisher & Paykel Healthcare company belong to?
The Fisher & Paykel Healthcare sector is Healthcare.
